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Abstract 
Toll like receptor 3 (TLR3) belongs to a family of pattern recognition receptors that recognise molecules 
found on pathogens referred to as pathogen associated molecular patterns (PAMPs). Its involvement in 
innate immunity is well known but despite its presence in the central nervous system (CNS), our 
knowledge of its function is limited. Here, we have investigated whether TLR3 activation modulates 
synaptic activity in primary hippocampal cultures and induced pluripotent stem cell (iPSC)-derived 
neurons. Synaptically driven spontaneous action potential (AP) firing was significantly reduced by the 
TLR3 specific activator, poly I:C, in a concentration-dependent manner following both short (5 min) 
and long exposures (1h) in rat hippocampal cultures.  Notably, the consequence of TLR3 activation on 
neuronal function was reproduced in iPSC-derived cortical neurons, with poly I:C (25µg/ml, 1h) 
significantly inhibiting sAP firing. We examined the mechanisms underlying these effects, with poly 
I:C significantly reducing peak sodium current, an effect dependent on the MyD88-independent TRIF 
dependent pathway. Furthermore, poly I:C (25µg/ml, 1h) resulted in a significant reduction in miniature 
excitatory postsynaptic potential (mEPSC) frequency and amplitude and significantly reduced surface 
AMPAR expression.  These novel findings reveal that TLR3 activation inhibits neuronal excitability 
and synaptic activity through multiple mechanisms, with this being observed in both rat and human 
iPSC-derived neurons.   These data might provide further insight into how TLR3 activation may 
contribute to neurodevelopmental disorders following maternal infection and in patients with increased 
susceptibility to herpes simplex encephalitis. 
 
Keywords: TLR3, TRIF, poly I:C, neuron, iPSC-derived neuron, action potential, Na+ channel, 
mEPSCs. 
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1. Introduction 
Toll like receptors (TLRs) are pattern recognition receptors (PRR) that classically play a pivotal role in 
activating innate immunity in response to invading pathogens by sensing a diverse range of pathogen 
associated molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs) (Gay et 
al., 2014; Achek et al., 2016). To date, 11 human and 13 mouse members of the TLR family have been 
identified with TLRs 1, 2, 4, 5, 6, 10 and 11 being expressed on the membrane surface for ligand 
recognition whereas TLRs 3, 7, 8 and 9 are primarily expressed intracellularly on endosomes where 
they  are activated by pathogen nucleic acids. All TLRs, with the exception of TLR3 and under certain 
circumstances, TLR4, use the MyD88-dependent pathway resulting in the release of a diverse range of 
inflammatory cytokines (Gay et al., 2014; Achek et al., 2016). In contrast, TLR3, which is activated by 
double stranded RNA (dsRNA), acts through a MyD88-independent, TIR domain-containing adaptor 
protein inducing IFN-ȕ75,)-dependent pathway which when activated, results in the production of 
type one interferons (IFNs; Gay et al., 2014; Achek et al., 2016). 
 
Within mammalian cells, TLRs are known to be expressed on a variety of cell types including numerous 
immune cell types (Gay et al., 2014; Achek et al., 2016).  However, it is now known that TLRs are 
expressed in cells of the central nervous system (CNS) with expression initially proposed to be in 
astrocytes, microglia and oligodendrocytes but it is now established that neurons and neuronal 
progenitor cells also express TLRs (Okun et al., 2011; Barichello et al., 2015).  TLRs have been 
proposed to play a role in CNS diseases including $O]KHLPHU¶V GLVHDVH 3DUNLQVRQ¶V GLVHDVH DQG
multiple sclerosis (Lucas et al., 2006) implicating TLRs as therapeutic targets in these diseases 
(Gambuzza et al., 2014). In addition, TLRs have been implicated in neurodevelopment including 
modulating neural precursor cell proliferation and fate, adult neurogenesis and neurite outgrowth (Bsibi 
et al., 2010; Barichello et al., 2015, Vontell et al., 2015).   Indeed, one TLR that has been implicated in 
both neuronal development and CNS disease is TLR3. 
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Within the CNS, TLR3 is known to be expressed on neurons, astrocytes, microglia and 
oligodendrocytes (Okun et al., 2011) with its activation shown to negatively regulate axonal growth, 
reduce neural precursor cell proliferation and contribute to the long term CNS effects associated with 
maternal viral infection including Zika virus-induced microcephaly (Cameron et al., 2007; Lathia et al., 
2008; Reisinger et al., 2015; Faizan et al., 2016; Chen et al., 2017). In addition, TLR3 was also revealed 
to regulate spinal cord synaptic transmission and central sensitisation, thus highlighting its critical role 
in pruritus (Liu et al., 2012). Within the brain itself, TLR3 deficiency in mice leads to enhanced working 
memory, novel object recognition and contextual fear conditioning as well as increased hippocampal 
neurogenesis and GluA1 subunit expression (Okun et al., 2010).  In contrast, direct activation of TLR3 
via intracerebral infusion of a TLR3 ligand has been shown to result in impaired working, but not 
spatial, memory (Okun et al., 2010) and increased seizure susceptibility and epileptiform activity (Galic 
et al., 2009; Costello et al., 2013) with TLR3 also proposed to contribute to disease progression when 
investigated using a pilocarpine model of epilepsy (Gross et al., 2017).    
 
Despite these recent findings, it remains to be elucidated what underlies the impairment in hippocampal 
memory retention and the exact mechanisms involved. In the present study we reveal that both short 
and long term exposure of rat primary hippocampal neurons to the TLR3 ligand, 
polyinosinic:polycytidylic acid (poly I:C), reversibly inhibits spontaneous action potential firing. These 
effects are mediated via the inhibition of Na+ channel function and a reduction in AMPA receptor 
expression and are dependent on the classical TLR3-TRIF pathway but are independent of astrocytic 
activation.  Finally, consistent with its activation in rat cultures, TLR3 activation inhibits AP firing and 
Na+ channel function in human iPSC-derived cortical neurons. 
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2. Materials and Methods 
  
All experimental procedures were performed in accordance with UK legislation including the Animals 
(Scientific Procedures) Act 1986 and with approval of the University of Strathclyde Animal Welfare 
and Ethical Review Body (AWERB).  Ethical permission for the use of patient-derived iPSCs was 
obtained from the National Hospital for Neurology and Neurosurgery and the Institute of Neurology 
joint research ethics committee (study reference 09/H0716/64; see Sposito et al., 2015).   
 
2.1 Rat primary hippocampal culture: Rat primary hippocampal culture: Primary rat hippocampal 
cultures were prepared as described previously (Gan et al., 2011) and maintained in a humidified 
LQFXEDWRUDW&&2IRUXSWRGD\VLQYLWUR',9SULRUWRIXQFWLRQDOVWXGLHV&\WRVLQHȕ-D-
arabinofuranoside (Ara-C, 10µM, Sigma, UK) was added after 5 DIV to prevent further glial cell 
proliferation. Primary mouse hippocampal cultures were obtained from TLR3-/- breeding colonies 
(Jackson Labs, stock number: 005217) with TLR3+/+ cultures obtained from MKP-2+/+ breeding 
colonies (Abdul Rahman et al., 2016).     All experiments from both species were performed on cells 
taken from at least three separate cultures obtained from different animals.  
 
2.2 Human astrocyte and neuron co-culture: Cortical neurons were differentiated from human iPSCs 
as previously described (Sposito et al., 2015).  After 35 DIV, neurons were re-plated and co-cultured 
on top of human astrocytes (ScienCell cat# 1800, Caltag Medsystems, UK) on laminin and poly-
ornithine coated 13mm glass coverslips and incubated in incubated in a culture medium as described 
previously (Verheyen et al., 2015). After plating, the media was supplemented with DAPT (10 µM, 
Sigma, UK) for 3 media changes in the first week. This media was then completely replaced and the 
co-cultures maintained in the supplemented Neurobasal-A:DMEM medium (Verheyen et al., 2015) and 
kept in a humidified incubator at 37ºC/5% CO2 with half the media replaced twice weekly. All 
experiments were performed on cells taken from two separate differentiations of iPSCs into cortical 
neurons WKDWZHUHFXOWXUHGIRU',9 
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2.3 Electrophysiology: Cultures were perfused continuously with a HEPES-buffered saline (HBS) 
composed of (in mM): NaCl 140, KCl 5, MgCl2 2, HEPES 10, D-glucose 10 and CaCl2 2, pH 7.4 ± 
0.02. Fire polished borosilicate glass microelectrodes (4-0ȍ, Harvard Apparatus, UK) were filled 
with an internal solution containing (in mM): KMeSO3 130, KCl 20, HEPES 10, EGTA 0.5, MgATP 4 
and GTP 0.3, pH 7.2. All experiments were performed  at room temperature (21-23qC) using an 
Axopatch-200B amplifier (Molecular Devices, USA) connected to a personal computer interfaced with 
Digidata 1322A interface (Molecular Devices, USA) and captured using pClamp9.0 software 
(Molecular Devices, USA). In all experiments, neurons with an initial resting membrane potential 
greater than -55mV were rejected. Spontaneous action potential (sAP) firing, digitised at 5kHz, was 
recorded from neurons held at -65 mV using whole cell patch clamp in current clamp mode.   For 
current±voltage relationships, cells were held at -70mV in voltage clamp mode with 10mV increments 
at 10s intervals. mEPSCs, digitized at 5 kHz, were recorded at -70 mV for 5 minute periods in voltage-
clamp mode.. Data were analysed offline using pClamp9.2 software (Molecular Devices, USA) and 
MiniAnalysis software (Synaptosoft, USA). 
 
2.4 Immunocytochemistry: To examine surface AMPA receptor labelling, staining was performed on 
rat hippocampal cultures (10-12 DIV) WUHDWHG ZLWK YHKLFOH RU SRO\ ,& ȝJ PO IRU K WKHQ
immediately fixed with ice cold 4% paraformaldehyde for 10 minutes followed by blocking non-
specific binding using a blocking buffer solution (5% FBS v/v and 1% BSA w/v in PBS, all Sigma, 
UK) for 30 minutes.  The cultures were then incubated with a N-terminal GluA1antibody (1:100 in 
blocking buffer, kindly donated by Dr A. Irving, see Moult et al., 2010) at 4°C overnight followed by 
corresponding secondary antibodies (Alexa Fluor 488 anti-sheep, 1:200 dilution, Thermo Fisher , UK) 
in blocking solution for 60 min at room temperature. Image acquisition was performed taking random 
images with an Olympus BX51W1 microscope with a Q-imaging digital camera, with images acquired 
using WinFluor v3.4.4 imaging software (J. Dempster, University of Strathclyde, Glasgow, UK). 
GluA1 fluorescence intensity from vehicle and poly I:C treated cultures was measured using ImageJ 
software (NIH, USA) with 50 µm regions of interest added to 5 randomly selected neurites per 
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coverslip. For neurites, n represents the number of neurites from at least three separate cultures, with 
all data expressed as mean ± S.E.M.   
 
2.5 Neuronal Transfection: A plasmid containing a human TLR3 p.Ala795Pro mutant (A795P TLR3, 
Verstak et al., 2013) was subcloned into the mammalian expression vector, pcDNA3.1/Zeo (Thermo 
Fisher, UK) and verified by Sanger sequencing (GATC Biotech, Cologne, Germany). Plasmid DNA for 
mammalian cell transfections were prepared using EndoFree® Plasmids kits (Qiagen, UK). For 
hippocampal neuronal transfections, cultures (9-10 DIV) were placed in 4 well plates containing 
FRQGLWLRQHGPHGLDȝO7UDQVIHFWLRQZDVDFKLHYHGXVLQJ/LSRIHFWDPLQHThermo Fisher, UK) 
DFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVZLWKHLWKHU*)3DORQHȝJPORU*)3ȝJPODQG
$37/5ȝJPOLQFOXGHG7KHWUDQVIHFWLRQUHDJHQWVȝOZHUHDGGHGGLUHFWO\WRWKHFXOWXUHV
for 3h, following which the transfection media removed and replaced by conditioned media.  The 
cultures were maintained post-transfection in a humidified incubator at 37ºC/5% CO2, with experiments 
performed 24-48h post transfection.   
2.6 Cytokine quantification: Secreted cytokines were measured, in relation to standard curves, in rat 
primary hippocampal culture supernatants using the Rat IL-10 Quantikine ELISA Kit (R1000), Rat 
TNF-D Quantikine ELISA Kit (RTA00) and the Mouse/Rat CCL5/RANTES Quantikine ELISA Kit 
005DOO5	'6\VWHPVDFFRUGLQJWRPDQXIDFWXUHU¶VLQVWUXFWLRQV 
2.7 Western blotting:  Primary rat hippocampal cultures were treated with either vehicle or poly I:C 
ȝJPOIRUKour, washed in ice-cold PBS and then lysed in lysis buffer (50 mM Tris, 150 mM 
NaCl, 1 mM EDTA, 1 % Triton X-100, 0.05% deoxycholate, pH7.4, containing a phosphatase and 
protease inhibitor cocktail (Sigma Aldrich). Lysates were then centrifuged at 16,000 rpm for 10 
minutes and the protein content of the supernatant estimated. Equal amounts of protein were heated to 
95 oC in SDS sample buffer for 5 minutes, resolved by SDS-PAGE and transferred to nitrocellulose 
for immunoblotting analysis. Primary antibodies (caspase-3, Cell Signalling Cat# 9665S; total 
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GluA1, Abcam Cat# 109450; GluA1 phospho S845, Abcam Cat# 76321, GluA1 phospho S831 
Abcam Cat# 109464, Na+ Sigma Cat# S8809) were used at 1:1000 in PBS-T and secondary antibodies 
(IR dye; LICOR) at 1:10,000.  
 
2.8 Statistics: $OOGDWDDUHH[SUHVVHGDVPHDQ6(0'DWDZHUHFRPSDUHGE\XQSDLUHG6WXGHQW¶VW-
tests, one-way or two-ZD\DQDO\VLVRIYDULDQFHZLWK'XQQHWW¶VRU7XNH\¶VFRPSDULVRQDVDSSURSULDWH
with differences considered significant when P < 0.05. 
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3. Results 
 
3.1 TLR3 activation reduces spontaneous action potential frequency in rat primary hippocampal 
cultures. 
Application of the TLR3 agonist, poly I:C (5min) induced a reversible and concentration-dependent 
reduction in sAP frequency  in cultured hippocampal neurons (25µg/ml, 82.3 ± 5.6% of control, n=6, 
p<0.05; 200µg/ml, 58.1 ± 8.4% of control, n=6, p<0.01, Fig. 1A-D). In addition, a reversible 
concentration-dependent reduction of sAP frequency was observed upon extended exposure (1h) to 
poly I:C (0.1µg/ml, 90.7 ± 13.7% of control, n=6; 1µg/ml, 42.7 ± 12.4% of control, n=6, p<0.01; 
25µg/ml, 1.0 ± 0.5% of control, n=8, p<0.001,Fig. 2A-B & E). Furthermore another TLR3 agonist, poly 
A:U ȝJPO, 1h) also resulted in a significant reduction in sAP frequency (31.8 ± 5.4% of control, 
n=5, p<0.01, Fig. 2E). In contrast, application of the TLR2/4 agonist, lipopolysaccharide (LPS, 
ȝJPO, 1h) had no significant effect on sAP frequency (80.4 ± 10.1% of control, n=7, Fig. 2E).  In 
DGGLWLRQQHLWKHUSRO\,&ȝJPOPLQP9LQFUHDVHFRPSDUHGWRFRQWUROQ QRUSRO\
,&ȝJPOKYHKLFOHFRQWUROP9Q SRO\,&P9Q DOWHUHGWKHQHXURQDO
resting membrane potential.  As TLR3 is expressed on both neuronal and non-neuronal cells, we also 
examined whether the effects of poly I:C were mediated directly via neuronally expressed TLR3 or 
indirectly via astrocytic TLR3. Hence, we inhibited astrocyte function using fluoroacetatH)$Fȝ0
3h) which we have used to probe astrocyte function in previous studies (17). FAc had no significant 
effect on sAP frequency (144 ± 29% of control, n=5, Fig. 2F) whereas poly I:C (25µg/ml, 1h) still 
significantly reduced sAP frequency following FAc pre-treatment (9.3 ± 3.7% of control, n=5, p<0.001, 
Fig. 2F).    
 
Given the recent surge in interest in the use of human stem cell derived neurons as a potential means to 
overcome the known translational issues associated with CNS research, we also examined the 
consequence of TLR3 activation on sAP firing in human iPSC-derived cortical neurons co-cultured 
with human astrocytes.  In agreement with our findings in rat primary cultures,  sAP firing was 
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significantly reduced following exposure to poly I:&ȝJPOKZLWK sAP firing reduced to 8 ± 2% 
of vehicle-treated controls (control (n=6) v poly I:C treated (n=5), p<0.05, Fig. 2C, D & E).  
 
3.2 TLR3 activation impairs Na+ channel function and reduces AMPA receptor surface 
expression.  
Having demonstrated that TLR3 activation suppresses sAP firing, we next investigated the possible 
mechanisms underlying this effect. Given that Na+ channels are critical for AP firing, we investigated 
whether modulation of Na+ channel function was a mechanism by which TLR3 activation inhibited sAP 
firing. Poly I:C application (200µg/ml, 5min) significantly reduced Na+ current density compared to 
vehicle treated controls (vehicle control (n=13) v poly I:C treated (n=7), F= 9.76, p=0.002) with peak 
Na+ current density  being 75 ± 7% of control, (P<0.05, Fig. 3A). Furthermore, poly I:C (25µg/ml, 1h) 
reduced Na+ current density when compared to vehicle treated control cultures (vehicle control (n=21) 
v poly I:C treated (n=5), F= 123.89, p<0.001) with peak Na+ current density reduced to 17 ± 7% of 
control (p<0.001, Fig. 3B), which fully recovered upon washout with conditioned media (3h, 98 ± 6% 
of control, n=8, Fig. 3C). Poly I:C (25µg/ml, 1h) also resulted in a 10mV positive shifted in peak Na+ 
current density but analysis of Na+ channel activation revealed no significant difference between vehicle 
(n=21) and poly I:C-treated neurons (n=5, Fig. 3D).  Moreover, poly I:C (25µg/ml, 1h) did not alter 
Na+ channel expression levels as these were 116 ± 38% of vehicle treated controls. As AP firing in 
primary hippocampal cultures is known to be synaptically driven, we examined whether TLR3 
activation modulates miniature excitatory postsynaptic currents (mEPSCs) recorded in the presence of 
TTX (0.5µM). Poly I:C (200µg/ml, 5min) did not alter mEPSC frequency or amplitude whereas both 
the frequency (control, 0.4 ± 0.02 Hz, n=9; poly I:C treated, 0.001 ± 0.0005 Hz, n=7, p<0.05, Fig. 4A-
C) and amplitude (control, 8.4 ± 2.0 pA, n=9; poly I:C treated, 2.4 ± 1.2 pA, n=7, p<0.05, Fig. 4A, B 
& D) of mEPSCs were reduced in  poly I:C (25µg/ml, 1h) treated cultures. As TLR3 activation reduced 
the frequency and amplitude of mEPSCs and TLR3 has been reported to modulate AMPA receptor 
expression (13), we next investigated, using immunocytochemistry, the possibility that a reduction in 
AMPA receptor surface expression accounted for this observation. Exposure to poly I:C (25µg/ml, 1h) 
resulted in a significant reduction in AMPA receptor surface expression when compared to control 
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cultures (58 ± 2% of control, p < 0.001, Fig. 4E) whereas, using western blotting techniques, no change 
in GluA1 S831 phosphorylation (99.7 ± 7.1% of control, n=3, Fig. 4F), GluA1 S845 phosphorylation 
(95.5 ± 16.5% of control, n=3, Fig. 4F) , total GluA1 (114.5 ± 8.3% of control, n=3, Fig. 4F) or caspase 
3 activation (100.8 ± 22.5% of control, n=3, Fig. 4F)  was observed in poly I:C (25µg/ml, 1h) treated 
cultures when compared to vehicle treated controls. 
 
3.3 TLR3 inhibition of neuronal excitability requires the adaptor molecule TRIF. 
Having established that TLR3 activation reduces sAP firing via a reduction in neuronal excitability and 
synaptic activity, we next investigated whether these effects require the activation of the classical TLR3-
TRIF pathway. Experiments were performed in an attempt to confirm that poly I:C PHGLDWHVLW¶VDFWLRQ
via TLR3 using hippocampal cultures from TLR3+/+ and  TLR3-/- mice.  However, poly I:C (25µg/ml, 
1h) did not reduce sAP frequency in TLR3+/+ mouse cultures (101.8 ± 22.3% of vehicle treated controls 
(n=7) with sAP frequency also being unaffected in TLR3-/- cultures ( 95.5 ± 34.4% of vehicle treated 
controls, n=8).  Hence to confirm the role of TLR3 in rat cultures, we transfected neurons with A795P 
TLR3, a TLR3 mutated receptor that switches TLR3 activation from the classical TRIF pathway to the 
MyD88-dependent pathway (Verstak et al., 2013). In agreement with our earlier observation, poly I:C 
(25µg/ml, 1h)  significantly reduced the peak Na+ current density in GFP transfected cells (n=6, 
F=87.91, p<0.001) when compared to their vehicle-treated GFP controls (n=6) with peak Na+ current 
density reduced to 2 ± 15% of GFP control (n=6, p < 0.001, Fig. 5B). In contrast, poly I:C (25µg/ml) 
had no effect on the Na+  current density in neurons co-transfected with A795P TLR3 (A795P TLR3 
control (n=7) v poly I:C treated (n=7), F= 0.26, p=0.61) with the peak Na+ current density being 99 ± 
16% of control (Fig. 5A & B). :LWK7/5¶VDFWLRQVUHTXLULQJWKHDFWLYDWLRQRIWKH75,)SDWKZD\ZH
used ELISA to examine whether cytokines classically produced via the TLR3-TRIF pathway in immune 
cells, were induced following exposure of hippocampal FXOWXUHVWRSRO\,&ȝJPOK/HYHOVRI
RANTES were similar in conditioned media from both vehicle and poly I:C treated cultures (vehicle: 
80 ± 9 pg/ml v poly I:C 81 ± 11 pg/ml, n=4 for both conditions) whereas levels of TNF-ĮDQG,/-10 
were undetectable in both conditions. 
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4. Discussion 
In the present study, we show that TLR3 activation impairs neuronal excitability and synaptic activity 
in rat hippocampal neurons via the inhibition of Na+ channel function and reduced AMPA receptor 
expression.  Furthermore, we provide evidence that the TLR3-mediated effects are mediated directly 
via neuronal TLR3 and the reduction in Na+ channel function relies on the activation of the MyD88-
independent pathway. In addition, we reveal that TLR3 activation inhibits sAP firing in human iPSC-
derived neurons. 
  
4.1 TLR3 activation inhibits action potential firing. 
It is well established that TLRs play a key role in the activation of innate immunity by recognising both 
PAMPs and DAMPs with TLR3 proposed to play a crucial role in antiviral responses (Gay et al., 2014; 
Achek et al., 2016; Miller wet al., 2016). Indeed, this applies to CNS viral infections but evidence 
indicates a dichotomy for TLR3 in which it plays a protective and/or a detrimental role in CNS viral 
infections and pathogenesis (Perales-Linares and Navas-Martin, 2013). In addition to its well 
established role in innate immunity, TLR3 is expressed in neurons, astrocytes, microglia and 
oligodendrocytes within the CNS (Costello et al., 2013; Miller et al., 2016), but the consequence of its 
activation on neuronal excitability and synaptic activity remains unclear.  Our data shows that TLR3 
activation reduces action potential firing in primary rat hippocampal cultures, an effect that is 
independent of astrocytic activation. This reduction in neuronal activity may underlie the finding that 
TLR3 activation following direct infusion of poly I:C into the hippocampus results in impaired working 
memory (Okun et al., 2010). This study also revealed that TLR3-/- mice had improved hippocampal-
dependent memory retention, with these findings indicating that TLR3 is an endogenous suppressor of 
hippocampal memory retention but whether endogenous activator(s) of TLR3 within the CNS exist 
remains to be elucidated (Okun et al., 2010). Our data supports this view that TLR3 activation modulates 
neuronal function, however our experiments using mouse hippocampal cultures are a caveat to this but 
given it is well documented that species differences occur with regard to TLR3 function (Zhang et al., 
2013; Carty et al., 2014), further investigation into this is beyond the scope of this study.  In contrast to 
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the data presented here, it has previously been shown that systemic injection of poly I:C results in 
increased hippocampal network excitability (Costello et al., 2013)ZLWKWKLVEHLQJGHSHQGHQWRQ,)1ȕ
production from microglia and astrocytes. These differences may be a result of direct neuronal TLR3 
activation with no role for glial cells in the present study whereas the increased excitability observed 
following systemic poly I:C injection results from an inflammatory response, which in part includes the 
activation of glial cells. However further investigations are required to examine these discrepancies. In 
addition, poly I:C has been shown to induce inward currents and elicit action potential firing in dorsal 
root ganglion cells (DRGs), in a TLR3-dependent manner (Liu et al., 2012). This action is proposed to 
underlie the increased neuronal excitability associated with pruritus and implies TLR3 as a potential 
target for anti-itch treatments.  However, why the dichotomy exists between the effects of TLR3 
activation on DRG and hippocampal neuronal excitability is as yet unknown.    
 
4.2 TLR3 activation impairs AP firing in human iPSC-derived neurons. 
Having characterised the effects of TLR3 activation in rat hippocampal cultures, we then extended our 
investigation to determine whether similar effects are observed in human iPSC-derived cortical neurons. 
There has been intense recent speculation regarding the physiological credibility of iPSC-derived 
neurons but several recent studies have revealed electrical and synaptic maturity depending on the 
culture conditions (Livesey et al., 2016). The iPSC-derived neurons utilised in the present study exhibit 
spontaneous AP firing, thus we are confident that they are indeed physiologically viable for the present 
study. Hence, we show for the first time that exposure of human cortical neurons to poly I:C results in 
impaired AP firing similar to that seen in rat hippocampal cultures, with our data indicating that TLR3 
is indeed present in human neurons in agreement with previous studies (Peltier et al., 2010; Vontell et 
al., 2013). Whilst these iPSC-derived neurons are electrically and synaptically mature when grown 
under the current conditions, they are still developmentally immature (Livesey et al., 2016). As there is 
intense interest in the relationship between maternal infection and neurodevelopmental disorders 
(Cordeiro et al., 2015) and with animal models of prenatal infection being used extensively (Meyer, 
2014; Ibi and Yamada, 2015; Reisinger et al., 2015), our observation  may offer another mechanism, in 
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addition to the activation of inflammatory pathways, by which viral infections contribute to 
neurodevelopmental disorders. 
4.3 TLR3 modulation of action potential firing involves modulating Na+ channels and 
neurotransmitter release. 
Having established that TLR3 activation reduces spontaneous AP firing, we next sought to examine the 
mechanisms that underlie this.  As spontaneous AP firing in primary hippocampal cultures is dependent 
on Na+ channel activation and is synaptically driven (Gan et al., 2011), we examined the consequence 
of TLR3 activation on Na+ channel function and mEPSCs. To the best of our knowledge, our data 
reveals for the first time that TLR3 activation reversibly reduces Na+ channel currents following both 5 
minute and 1 hour exposure to poly I:C without any effect on resting membrane potential. In DRGs, 
TLR3 activation results in inward currents that are suggested to be mediated via coupling with ion 
channels (Liu et al., 2012), but which channels this involved was not investigated further. Since the first 
discovery of the role of Na+ channels in AP generation, it is accepted that inhibition of Na+ channel 
function results in impaired neuronal excitability with Na+ channel dysfunction associated with a 
number of channelopathies (Kruger and Isom, 2016). Hence the TLR3-mediated Na+ channel inhibition 
is likely to underlie, at least in part, the reduction in spontaneous AP firing observed following exposure 
to poly I:C. As mentioned earlier, whether endogenous CNS activators exist for TLR3 remains to be 
elucidated, but recently two Toll receptors were shown to be neurotrophin receptors in the Drosophila 
CNS (McIlroy et al., 2013).  Whether this extends to TLRs in mammalian systems remains unknown, 
but it has been reported that neurotrophin 3 reduces sodium channels expression in DRGs (Wilson-
Gerwing et al., 2008). However, our data indicates no change in sodium channel expression following 
exposure to TLR3 activation under our experimental conditions but it would be intriguing to determine 
whether the connection between neurotrophins and TLR3 holds true in rat hippocampal and human 
neurons. We also examined whether TLR3 activation modulated synaptic activity given that AP firing 
in primary hippocampal cultures is synaptically driven. Short term application of poly I:C had no effect 
on mEPSCs whereas a 1 hour exposure resulted in a significant decrease in both frequency and 
amplitude of mEPSCs.  These data indicate that prolonged TLR3 activation mediates its effect on 
mEPSCs postsynaptically. Hence, we examined GluA1 surface expression in our cultures and reveal 
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that prolonged TLR3 activation results in reduced expression.  This reduced GluA1 surface expression 
is independent of S831 and S845 dephosphorylation, sites proposed to be involved in AMPA receptor 
trafficking (Henley and Wilkinson, 2016).  Other phosphorylation sites are also proposed for AMPA 
receptor trafficking but receptor internalisation may also depend on activation of other signalling 
pathways including caspase-3 (Li et al., 2010).  Given that TLRs are linked to caspase activation (Gay 
et al., 2014), we also examined whether poly I:C exposure activated caspase-3 in our rat hippocampal 
preparations.  However no change is caspase-3 activity was observed which indicates an as yet 
undefined mechanism underlies the TLR3-mediated GluA1 internalisation. Our findings therefore 
indicate that reduced GluA1 surface expression underlies the effect on mEPSCs and combined with the 
effects on Na+ channel function, results in impaired spontaneous AP firing.    
 
Given our findings that the effects of TLR3 activation on neuronal excitability and synaptic activity are 
independent of astrocytic activation, we next examined whether these neuron specific effects were 
mediated through the classical TLR3-MyD88-independent pathway. In experiments utilising mouse 
TLR3+/+ and TLR-/- hippocampal cultures, in contrast to the effects observed in rat hippocampal cultures, 
poly I:C was without effect on sAP firing, indicating species variation regarding the consequence of 
TLR3 activation on neuronal function.  Given that TLR species variation is acknowledged (Zhang et 
al., 2013; Carty et al., 2014), we show that neuronal overexpression of A795P TLR3 abolished poly 
I:C-induced Na+ channel inhibition revealing that the TLR3-TRIF pathway is indeed required for the 
actions observed here. This mutant TLR3 has previously been utilised to highlight that TLR adaptor 
specificity is controlled by small regions of the Toll/IL-1R domain (Verstak et al., 2013).  Indeed, the 
fact that A795P TLR3 switches to the MyD88-dependent pathway supports our findings that LPS has 
no effect on AP firing in our studies.  Having confirmed that the effects of poly I:C require the TLR3-
MyD88-independent pathway, our findings that poly I:C did not induce the production of cytokines 
classically produced by immune cels following TLR3 activation suggest that an alternative and as yet 
unknown TLR3-mediated pathway(s) is responsible for the effects observed in the present study.  These 
data are also interesting given the known link between the TLR3-MyD88-independent pathway and 
herpes simplex encephalitis (HSE) as it is now well documented that a number of patients who have 
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identified genetic deficiencies in this pathway have an increased susceptibility to HSE (Zhang et al., 
2007; Guo et al., 2011; Andersen et al., 2015; Sironi et al., 2017), presumably as the virus is more 
neuroinvasive.  In addition, given the role of trans-synaptic spread in viral propagation (Miller et al., 
2016), one could speculate that an intact TLR3-MyD88-independent pathway is an alternative 
mechanism to the canonical immune response by which to control the spread of viral infections.   
 
5. Conclusion 
Taken together, our novel data reveals for the first time that activation of neuronally expressed TLR3 
results in impaired neuronal function. This extends our understanding of the role of TLR3 in modulating 
CNS function both under physiological conditions, but potentially under pathophysiological conditions 
including those observed during maternal viral infections and during HSE. 
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Figure legends 
Fig. 1. Short term poly I:C application reduces spontaneous AP firing. A + B) Representative traces 
of AP firing from neurons exposed to vehicle and poly I:C (200µg/ml) respectively. C) Time course 
revealing concentration-dependent and reversible effects of poly I:C application on spontaneous AP 
firing. D) Bar chart summarising the maximum effect of poly I:C on spontaneous AP firing, *P < 0.05, 
**P < 0.01. Data are mean ± S.E.M, with Qfor each data set taken from at least 3 different cultures.  
 
Fig. 2. Chronic poly I:C application results in a concentration dependent but astrocyte 
independent reduction in AP firing in both rat and human neurons. A-B) Representative traces of 
AP firing from rat hippocampal neurons and C-D) human iPSC-derived neurons exposed to vehicle, 
poly I:C (1µg/ml, 1h) and  poly I:C (25µg/ml, 1h). E) Bar chart summarising the concentration 
dependent effect of poly I:C on spontaneous AP firing in both rat and human neurons. F) Bar chart 
summarising the lack of effect of the astrocyte inhibitor, FAc, on poly I:C-induced inhibition of 
spontaneous AP firing. *P < 0.05, **P < 0.01, ***P < 0.001. Data are mean ± S.E.M, with QIRUHDFK
data set taken from at least 3 different cultures for rat neurons and from at least 3 differentiations of 
iPSCs for human neurons. 
 
Fig. 3. Short term and long term TLR3 activation significantly reduces Na+ current density. A) I-
V curve revealing short term poly I:C (25µg/ml, 5 min) inhibits Na+ current density. B) I-V curve 
revealing effects of long term poly I:C(25µg/ml, 1h) on Na+ current density. C) Bar chart summarising 
the effect of short term poly I:C on peak Na+ current. D) Activation curves are similar in the absence 
and presence of poly I:C (25µg/ml, 1h) , *P < 0.05, ***P < 0.001. Data are mean ± S.E.M, ZLWKQ
for each data set taken from at least 3 different cultures. 
 
 
 
 
Control PIC 
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Fig. 4. Long term TLR3 activation significantly reduces frequency and amplitude of mEPSCs and 
surface AMPAR expression. A + B) Representative traces displaying mEPSCs in the absence and 
presence of poly I:C (25µg/ml, 1h). C + D) Bar charts revealing no effects of poly I:C (25µg/ml, 1h) on 
mEPSC frequency and amplitude respectively. E) Representative images and bar chart revealing the 
effects of poly I:C (25µg/ml, 1h)  on AMPAR surface expression. F) Representative blots and bar chart 
revealing the effects of poly I:C (25µg/ml, 1h)  on AMPAR and caspase 3 protein expression.  ***P < 
0.001. Data are mean ± S.E.M, ZLWKQ7 for each data set taken from at least 3 different cultures. Scale 
bar = ȝP 
 
Fig. 5. TLR3 mediated inhibition of Na+ current density is abolished in A795P TLR3 transfected 
neurons. A) I-V curve revealing effects of poly I:C on Na+ current density observed in A795P TLR3 
transfected neurons. B) Bar chart summarising the effect of poly I:C on peak Na+ current density in 
GFP- and A795P TLR3 transfected neurons. ***P < 0.001. Data are mean ± S.E.M, ZLWKQIRUHDFK
data set taken from at least 3 different cultures. 
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Supplemental Fig. 1. Full, untruncated images of the 
gels used to generate data in Fig. 4F.
